Novogenia AG (MUN:7V0)
6.05
-0.25 (-3.97%)
Last updated: Nov 18, 2026, 8:00 AM CET
Novogenia AG Market Cap
Novogenia AG has a market cap or net worth of €72.6 million as of November 18, 2026. It is the 26,056th most valuable company in the world and the 352nd biggest in Germany. Its market cap has decreased by 7.63% in one year.
Market Cap
72.60M
Enterprise Value
25.66M
Revenue
52.35M
Global Rank
Country Rank
#352 Germany
PE Ratio
n/a
ChartMarket Cap Chart
Since November 2, 2021, Novogenia AG's market cap has increased from 21.30M to 72.60M, an increase of 240.85%. That is a compound annual growth rate of 27.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 72.60M | -21.94% |
| Dec 22, 2025 | 93.00M | -14.36% |
| Dec 29, 2023 | 108.60M | -21.30% |
| Dec 30, 2022 | 138.00M | 88.52% |
| Dec 13, 2021 | 73.20M | 243.66% |
| Nov 2, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.32B |
| 2invest AG | 37.71M |
| Biomark Diagnostics | 25.98M |
| Vidac Pharma Holding | 11.10M |
| Chosa Oncology AB | 3.35M |
| Paion AG | 328.15K |
| bioXXmed AG | 254.19K |
| co.don AG | 133.62K |